How plan sponsors, insurers are considering coverage of weight-loss drugs amid rising use of Ozempic
Canadian plan sponsors and insurers are revisiting how they classify obesity drugs under their benefits plans, amid plan members’ rising demand for Ozempic as a weight-loss treatment. Ozempic, also known under the generic name semaglutide, is a drug used to treat type 2 diabetes. However, the medication has also been credited as a weight-loss treatment, […]
- July 20, 2023 July 19, 2023
- 09:00